4 recruiting, 2 completed, 1 terminated. 2 Not applicable, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Recruiting 2 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Cerebral Palsy, Dyskinetic: new trials by email Literature Review of Cerebral Palsy, Dyskinetic trials Research Report on Cerebral Palsy, Dyskinetic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders Neurodevelopmental Disorders, Neurodevelopmental Disorders (NDD) | Recruiting | Healing Hope International | 100 | 2026-03-01 | 2026-03-25 | |
| Family-Centered Physiotherapy in Dyskinetic Cerebral Palsy Family-Centered Goal-Oriented Physiotherapy and Rehabilitation Application - Cerebral Palsy, Dyskinetic | Not applicable | Recruiting | Hacettepe University | 24 | 2024-10-15 | 2025-04-03 |
| Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy Trihexyphenidyl - Pediatric Disorder, Genetic Predisposition | Phase 1 | Recruiting | Children's Mercy Hospital Kansas City | 40 | 2024-10-15 | 2026-06-24 |
| Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects Focused Ultrasound Pallidotomy - Cerebral Palsy, Dyskinetic, Secondary Dystonia | Not applicable | Recruiting | Children's National Research Institute | 10 | 2024-01-26 | 2026-06-11 |
| Functional Benefits of Multisite Surgery for the Upper Limb of Children With Cerebral Palsy Cerebral Palsy, Spastic, Cerebral Palsy, Dyskinetic | Completed | Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française | 23 | 2020-07-09 | 2024-08-20 | |
| A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy TEV-50717 - Cerebral Palsy, Dyskinetic | Phase 3 | Terminated | Teva Branded Pharmaceutical Products R&D, Inc. | 44 | 2020-02-04 | 2024-04-22 |
| A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents TEV-50717, Placebo - Cerebral Palsy, Dyskinetic | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 63 | 2019-08-06 | 2023-09-08 |
Cerebral Palsy (7) · Dystonic Disorders (2) · Autism Spectrum Disorder (1) · Brain Injuries, Traumatic (1) · Chromosome Aberrations (1) · Congenital Abnormalities (1) · Developmental Disabilities (1) · DiGeorge Syndrome (1) · Down Syndrome (1) · Dystonia (1) · Emotional Regulation (1) · Fragile X Syndrome (1) · Genetic Diseases, Inborn (1) · Genetic Predisposition to Disease (1) · Hypoxia-Ischemia, Brain (1)
Brain Damage, Chronic (7) · Brain Diseases (7) · Central Nervous System Diseases (7) · Nervous System Diseases (7) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Mental Disorders (2) · Movement Disorders (2) · Neurologic Manifestations (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · 22q11 Deletion Syndrome (1) · Abnormalities, Multiple (1) · Aortic Stenosis, Supravalvular (1) · Aortic Valve Disease (1)
deutetrabenazine (2) · Trihexyphenidyl (1)
Teva Branded Pharmaceutical Products R&D, Inc. (2) · Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française (1) · Children's Mercy Hospital Kansas City (1) · Children's National Research Institute (1) · Hacettepe University (1) · Healing Hope International (1)
United States (5) · Denmark (2) · Israel (2) · Italy (2) · Poland (2) · Russia (2) · Spain (2) · Ukraine (2) · United Kingdom (2) · Belgium (1) · Canada (1) · France (1) · Slovakia (1) · Turkey (Türkiye) (1)
Chima Oluigbo, MD (1) · Dr. Tina Casoglos-Adamopoulos, OT, OTD, BCP (1) · Rose Gelineau-Morel, MD (1)
2018 (1), 2019 (1)